Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.
Hello Bello
Acquisition in 2023
Hello Bello is an online retailer based in Pacific Palisades, California, specializing in eco-friendly children's products. Founded in 2018, the company offers a diverse range of items made with plant-based ingredients and organic botanicals, including premium diapers, shampoo, body wash, baby wipes, bubble baths, diaper rash cream, sanitizer, and lotion. The brand aims to provide parents with high-quality, affordable alternatives for their children's necessities, positioning itself as a reliable choice in the market for those seeking natural and environmentally conscious baby care solutions.
AleraCare Holdings
Private Equity Round in 2023
AleraCare Holdings provides home and community-based healthcare and pharmacy services, including home infusion and a specialty and compounding pharmacy, and operates a healthcare center. It serves high-need and medically complex populations, offering specialty medications for oncology, rheumatoid arthritis, multiple sclerosis, Crohn's disease, and other chronic conditions to support convenient, complex treatment. The company collaborates with care partners, manufacturers, patients, and physicians across the western United States and is based in Phoenix, Arizona.
HealthCare.com
Series C in 2022
HealthCare.com is an online health insurance company that offers a data-driven shopping platform to assist American consumers in enrolling in individual health insurance and Medicare plans. Founded in 2014 and headquartered in New York City, the company utilizes artificial intelligence and machine learning to enhance user experiences, enabling customers to find, compare, and purchase insurance products that best meet their needs. HealthCare.com also markets proprietary health insurance and supplemental insurance products under the name Pivot Health. Its services include a comparison platform that provides expert advice, data, and personalized recommendations, empowering users to make informed decisions regarding their healthcare coverage. The company has been recognized as one of America's fastest-growing businesses, earning a spot on the Inc. 5000 list multiple times.
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.
DermCare Management
Private Equity Round in 2019
DermCare Management is a dermatology practice management company founded by experienced dermatology professionals. It focuses on partnering with dermatologists to enhance patient loyalty and practice growth by combining clinical expertise with management support. The company provides administrative assistance and resources, allowing dermatologists to concentrate on delivering high-quality care. DermCare Management aims to foster a team-oriented environment in healthcare, emphasizing collaboration and effective management to ensure the continued success of its partner practices. Through its services, DermCare Management addresses the unique challenges faced by dermatology practices, enabling them to thrive in a competitive landscape while maintaining a commitment to exceptional patient care.
Crown Laboratories
Private Equity Round in 2019
Crown Laboratories, Inc. is a specialty pharmaceutical company based in Johnson City, Tennessee, founded in 2000. The company focuses on producing both prescription and non-prescription drugs, as well as cosmetic products aimed at enhancing skin health. Its product portfolio includes a range of aesthetic solutions such as SkinPen and Skinfuse, beauty products like Body Blur and Beauty Blur, and therapeutic options including Blue Lizard and PanOxyl. Additionally, Crown Laboratories offers contract manufacturing services for various formulations including solid, liquid, and semi-liquid gels and creams. The company's commitment to dermatology drives its mission to improve the quality of life for consumers through effective skincare solutions.
Crown Laboratories
Private Equity Round in 2017
Crown Laboratories, Inc. is a specialty pharmaceutical company based in Johnson City, Tennessee, founded in 2000. The company focuses on producing both prescription and non-prescription drugs, as well as cosmetic products aimed at enhancing skin health. Its product portfolio includes a range of aesthetic solutions such as SkinPen and Skinfuse, beauty products like Body Blur and Beauty Blur, and therapeutic options including Blue Lizard and PanOxyl. Additionally, Crown Laboratories offers contract manufacturing services for various formulations including solid, liquid, and semi-liquid gels and creams. The company's commitment to dermatology drives its mission to improve the quality of life for consumers through effective skincare solutions.
Pharmaceutics International
Venture Round in 2016
Pharmaceutics International is a science-driven contract development and manufacturing company providing dosage form development and cGMP manufacturing services for biotech and specialty pharmaceutical clients in the United States and internationally. It offers a broad range of dosage forms, including tablets and capsules (hard gelatin and HPMC), soft gels, liquids, inhalations, sterile injectables, and coated beads; it also supports advanced manufacturing technologies such as lyophilization and handling of high-potency compounds, enabling clients to accelerate drug development while meeting regulatory requirements. The company provides pre-formulation and formulation development, clinical trial materials manufacturing, commercial manufacturing, clinical packaging and labeling, and clinical trial kit building and distribution. By integrating scientific insight with product knowledge, it aims to deliver safe, effective medicines and help clients navigate development and scale-up.